Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant: Knowledge to Action

Université Laval

$200,000.00

Dissemination of the Lupus Interactive Navigator - Measuring its uptake and impact on global health and self-care.

EF 2015-16

Résumé
Persons with lupus feel isolated, report poor health and are unsure of how to best manage their disease. This grant asks whether persons with lupus will use and uptake the information and services of the web-based lupus interactive navigator (LIN) on a regular basis and whether this uptake will be associated with better self-management, improved coping, higher sense of control over their life, and overall improved health. Systemic lupus erythematosus, or lupus, is an incurable chronic multi-organ inflammatory disease that affects preferentially young women. Unmet needs include a 15% excess in mortality, high morbidity and poor work outcomes. Despite prevalence of 1:2000, lupus is mostly unknown from the public and access to specialized care remains limited. Therefore, persons with lupus and their caregivers have difficulty finding high quality information relevant to their “lupus journey”. The LIN research team consist of a lupus clinical expert and researcher (Fortin), a clinical psychologist and behavioral researcher (DaCosta), and a health information specialist (Rochon). They were funded by CIHR to develop the LIN, a web-based navigator designed to promote self-care. The LIN is completed and ready for dissemination. The team will work with several stakeholders:Lupus Canada, the sole national lupus patient organization, will bethe principal Knowledge User (Haroun) (see letter of collaboration); other provincial lupus associations; the Canadian Network for Improved Outcomes in SLE (Peschken); and the Arthritis Alliance of Canada (Yale) that groups most arthritis stakeholders under a single umbrella. In addition, we assembled a group of patient advisers (Singer, Paradisis, Bachand-Côté) that will create a Patient Advisory Committee to work with the team. We will randomize CaNIOS centres to either immediate access to the LIN or usual care. At baseline, all patients in all centres will be contacted, given instructions according to their centre randomization and asked to fill in an online questionnaire using Fluidsurvey. At three months, a second online assessment will be performed before crossing over those from the centres randomized to usual care in order to now provide them with an access to the LIN. A final assessment will be performed at six months. Pre-post comparisons of LIN exposure over three months will be performed in all patients at the end of the study; comparison of LIN use vs usual care will be done at three months; and retention of use at six months after LIN exposure will be documented in the first group randomized to LIN. The main outcome will be the Patient Activation Measure (a valid tool that measures the level of patient engagement in their healthcare). Secondary outcomes will include variables describing access and use of the LIN as captured by the LIN server, coping and self-efficacy scales and global health status using the Short Form 36. We propose that the LIN will improve knowledge about lupus and will provide a much-needed source of reliable information while facilitating self-efficacy, better coping and self-care. After completion of this study, the LIN will be disseminated broadly to all lupus patients in Canada and work will start on developing an arthritis interactive navigator.
Programme
Operating Grant: Knowledge to Action
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
336507
Name
Fortin Paul R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Health systems / services
Prcname2
Operating Grant: Knowledge to Action
Projecttitle
Dissemination of the Lupus Interactive Navigator - Measuring its uptake and impact on global health and self-care.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$200,000
Cihrequipment2
$0
Programname2
Operating Grant: Knowledge to Action
Keyworddelim
Dissemination Strategy Of Health Information Technology; Navigation; Person-Centered Care; Randomized Trial; Systemic Lupus Erythematosus
Abstract
<html> <body> <p> <strong><em>Persons with lupus feel isolated, report poor health and are unsure of how to best manage their disease.</em></strong> This grant asks whether persons with lupus will use and uptake the information and services of the web-based lupus interactive navigator (LIN) on a regular basis and whether this uptake will be associated with better self-management, improved coping, higher sense of control over their life, and overall improved health.</p> <p>Systemic lupus erythematosus, or lupus, is an incurable chronic multi-organ inflammatory disease that affects preferentially young women. Unmet needs include a 15% excess in mortality, high morbidity and poor work outcomes. Despite prevalence of 1:2000, lupus is mostly unknown from the public and access to specialized care remains limited. <strong><em>Therefore, persons with lupus and their caregivers have difficulty finding high quality information relevant to their &ldquo;lupus journey&rdquo;.</em></strong> <br> </p> <p>The LIN research team consist of a lupus clinical expert and researcher (Fortin), a clinical psychologist and behavioral researcher (DaCosta), and a health information specialist (Rochon). They were funded by CIHR to develop the LIN, a web-based navigator designed to promote self-care. <strong><em>The LIN is completed and ready for dissemination.</em></strong> The team will work with several stakeholders:<i><b>Lupus Canada</b></i>, the sole national lupus patient organization, will be<i><b>the principal Knowledge User</b> (Haroun)</i> (see letter of collaboration); other provincial lupus associations; the Canadian Network for Improved Outcomes in SLE (Peschken); and the Arthritis Alliance of Canada (Yale) that groups most arthritis stakeholders under a single umbrella. In addition, we assembled a group of patient advisers (Singer, Paradisis, Bachand-C&ocirc;t&eacute;) that will create a Patient Advisory Committee to work with the team.<br> </p> <p> <strong><em>We will randomize CaNIOS centres to either immediate access to the LIN or usual care.</em></strong> At baseline, all patients in all centres will be contacted, given instructions according to their centre randomization and asked to fill in an online questionnaire using Fluidsurvey. At three months, a second online assessment will be performed before crossing over those from the centres randomized to usual care in order to now provide them with an access to the LIN. A final assessment will be performed at six months. Pre-post comparisons of LIN exposure over three months will be performed in all patients at the end of the study; comparison of LIN use vs usual care will be done at three months; and retention of use at six months after LIN exposure will be documented in the first group randomized to LIN. <strong><em>The main outcome will be the Patient Activation Measure (a valid tool that measures the level of patient engagement in their healthcare).</em></strong> Secondary outcomes will include variables describing access and use of the LIN as captured by the LIN server, coping and self-efficacy scales and global health status using the Short Form 36.<br> </p> <p> <strong><em>We propose that the LIN will improve knowledge about lupus and will provide a much-needed source of reliable information while facilitating self-efficacy, better coping and self-care.</em></strong> After completion of this study, the LIN will be disseminated broadly to all lupus patients in Canada and work will start on developing an arthritis interactive navigator.</p> </body> </html>
Competitiondate
201510
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Fortin, Paul R; Da Costa, Deborah M; Haroun, Vinita
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $200,000~ $0~